The largest database of trusted experimental protocols

Reduced nicotinamide adenine dinucleotide phosphate

Manufactured by Thermo Fisher Scientific

Reduced nicotinamide adenine dinucleotide phosphate is a coenzyme that participates in various cellular redox reactions. It serves as an electron carrier and plays a crucial role in energy metabolism and biosynthetic processes.

Automatically generated - may contain errors

Lab products found in correlation

2 protocols using reduced nicotinamide adenine dinucleotide phosphate

1

Microsomal Stability Assay for Drug Discovery

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mouse or human liver
microsomes and reduced nicotinamide adenine dinucleotide phosphate
(NADPH) were obtained from Fisher Scientific SL. This assay gives
information on the metabolic stability of early drug discovery compounds
based on liver microsomes. Microsome stability was tested by incubating
10 μM of test compounds (11 and 13) and verapamil (as positive metabolized control) with 1.0 mg/mL
hepatic microsomes (pooled human liver microsomes and pooled mouse
(CD-1) liver microsomes) in 0.1 M potassium phosphate buffer (pH 7.4)
with MgCl2 5 mM. The reaction was initiated by adding NADPH
(1 mM final concentration). Aliquots of 150 μL were collected
at defined time points (0, 5, 15, 30, 45, and 60 min) and added to
cold acetonitrile (150 μL) containing an internal standard (5
μg/mL warfarin) to stop the reaction and precipitate the protein.
After stopping the reaction, the samples were centrifuged at 4 °C
for 15 min and the loss of parent compounds was analyzed by HPLC–MS
using single ion mode (SIM) detection. Data were log transformed and
represented as half-life. All experiments were conducted by duplicate.
+ Open protocol
+ Expand
2

Microsomal Metabolic Stability Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human
liver microsomes and reduced nicotinamide adenine dinucleotide phosphate
(NADPH) were purchased from Fisher Scientific SL. This assay provides
information on the metabolic stability of early drug discovery compounds
based on liver microsomes. Microsome stability was tested by incubating
8 μM of the test compound and verapamil (as control) with 1.0
mg/mL hepatic microsomes (pooled human liver microsomes) in 0.1 M
potassium phosphate buffer (pH 7.4) with 5 mM MgCl2. The
reaction was initiated by adding NADPH (1 mM final concentration).
Aliquots of 150 μL were collected at defined time points (0,
5, 15, 30, and 60 min) and added to cold acetonitrile (150 μL)
containing an internal standard (5 μg/mL warfarin) to stop the
reaction and precipitate the protein. After stopping the reaction,
the samples were centrifuged at 4 °C for 15 min, and the loss
of the parent compound was analyzed by high-pressure liquid chromatography
coupled to mass spectrometry (HPLC-MS). Data were log transformed
and represented as half-life. All experiments were conducted in duplicates.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!